Lates News

Novartis reported a core operating profit of $4.93 billion in the fourth quarter, in line with market expectations. Core earnings per share for the fourth quarter were $2.03, slightly higher than the market estimate of $2.01. The core net profit for the fourth quarter was $3.89 billion, compared to the market estimate of $3.85 billion. Sales net revenue for the fourth quarter was $13.34 billion, slightly lower than the market estimate of $13.68 billion.